Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Elson

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Biochemical Pharmacology|July 28, 2023
Suppression of Ah Receptor (AhR) increases the aggressiveness of TNBC cells and 11-Cl-BBQ-activated AhR inhibits their growthDaniel J Elson, Bach D Nguyen, Nicholas A Korjeff, et al.
ACS Pharmacology & Translational Science|July 20, 2023
Induction of Aryl Hydrocarbon Receptor-Mediated Cancer Cell-Selective Apoptosis in Triple-Negative Breast Cancer Cells by a High-Affinity BenzimidazoisoquinolineDaniel J Elson, Bach D Nguyen, Sebastian Bernales, et al.
Plos One|June 2, 2021
A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesisMichael I Dorrell, Heidi R Kast-Woelbern, Ryan T Botts, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Biochemical Pharmacology|July 28, 2023
Suppression of Ah Receptor (AhR) increases the aggressiveness of TNBC cells and 11-Cl-BBQ-activated AhR inhibits their growthDaniel J Elson, Bach D Nguyen, Nicholas A Korjeff, et al.
ACS Pharmacology & Translational Science|July 20, 2023
Induction of Aryl Hydrocarbon Receptor-Mediated Cancer Cell-Selective Apoptosis in Triple-Negative Breast Cancer Cells by a High-Affinity BenzimidazoisoquinolineDaniel J Elson, Bach D Nguyen, Sebastian Bernales, et al.
Plos One|June 2, 2021
A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesisMichael I Dorrell, Heidi R Kast-Woelbern, Ryan T Botts, et al.
Pageof 2